1.
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
by Nation, Daniel A
Nature medicine, 2019-02, Vol.25 (2), p.270-276
2.
Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database
by Ringman, John M
Journal of neuropathology and experimental neurology, 2016-03, Vol.75 (3), p.284-290
3.
Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations
by Lee, Grace J
Journal of Neurology, Neurosurgery & Psychiatry, 2013-02, Vol.84 (2), p.154-162
4.
Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Disease
by Ringman, John M
Dementia and geriatric cognitive disorders, 2012-03, Vol.33 (1), p.1-5
5.
Diagnosing Depression in Alzheimer Disease With the National Institute of Mental Health Provisional Criteria
by Teng, Edmond, M.D., Ph.D
The American journal of geriatric psychiatry, 2008, Vol.16 (6), p.469-477
6.
Cortical and Hippocampal Atrophy in Patients with Autosomal Dominant Familial Alzheimer’s Disease
by Apostolova, Liana G
Dementia and geriatric cognitive disorders, 2011-10, Vol.32 (2), p.118-125
7.
Plasma Methionine Sulfoxide in Persons with Familial Alzheimer’s Disease Mutations
by Ringman, John M
Dementia and geriatric cognitive disorders, 2012-07, Vol.33 (4), p.219-225
8.
Propositional Density and Apolipoprotein E Genotype among Persons at Risk for Familial Alzheimer’s Disease
by Medina, Luis D
Dementia and geriatric cognitive disorders, 2011-12, Vol.32 (3), p.188-192
9.
The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families
by Murrell, Jill
Neurogenetics, 2006-11, Vol.7 (4), p.277-279
10.
Increased Prevalence of Significant Recurrent Headache in Preclinical Familial Alzheimer’s Disease Mutation Carriers
by Ringman, John M
Dementia and geriatric cognitive disorders, 2008-04, Vol.25 (4), p.380-384
11.
Donepezil Treatment in Ethnically Diverse Patients with Alzheimer’s Disease
by Tinklenberg, Jared R Jared R
The American journal of geriatric psychiatry, 2014-09-28, Vol.23 (4), p.384-390
12.
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
by Preische, Oliver
Nature medicine, 2019-02, Vol.25 (2), p.277-283
13.
Donepezil Treatment in Ethnically Diverse Patients with Alzheimer Disease
by Tinklenberg, Jared R., M.D
The American journal of geriatric psychiatry, 2015, Vol.23 (4), p.384-390
14.
Donepezil improves cognitive function and reduces decline in activities of daily living in people with severe Alzheimer’s disease
by Ringman, John M
Evidence-based mental health, 2006-11, Vol.9 (4), p.104-104
15.
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease
by Barthélemy, Nicolas R
Nature Medicine, 2020-03, Vol.26 (3), p.398-407
